COVID-19 Impact on Global Telmisartan, Market Insights and Forecast to 2026
- BMR3903750
- 118 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Telmisartan industry.
Based on our recent survey, we have several different scenarios about the Telmisartan YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3320.7 million in 2019. The market size of Telmisartan will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Telmisartan market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Telmisartan market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Telmisartan market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Telmisartan market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Telmisartan market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Telmisartan market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Telmisartan market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Telmisartan market.
The following manufacturers are covered in this report:
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Telmisartan Breakdown Data by Type
Injection
Freeze-Dried Powder
Telmisartan Breakdown Data by Application
Hospital Use
Clinic Use
Others
1.1 Telmisartan Product Introduction
1.2 Market Segments
1.3 Key Telmisartan Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Telmisartan Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-Dried Powder
1.5 Market by Application
1.5.1 Global Telmisartan Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Telmisartan Industry Impact
1.6.1 How the Covid-19 is Affecting the Telmisartan Industry
1.6.1.1 Telmisartan Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Telmisartan Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Telmisartan Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Telmisartan Market Size Estimates and Forecasts
2.1.1 Global Telmisartan Revenue 2015-2026
2.1.2 Global Telmisartan Sales 2015-2026
2.2 Telmisartan Market Size by Region: 2020 Versus 2026
2.2.1 Global Telmisartan Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Telmisartan Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Telmisartan Competitor Landscape by Players
3.1 Telmisartan Sales by Manufacturers
3.1.1 Telmisartan Sales by Manufacturers (2015-2020)
3.1.2 Telmisartan Sales Market Share by Manufacturers (2015-2020)
3.2 Telmisartan Revenue by Manufacturers
3.2.1 Telmisartan Revenue by Manufacturers (2015-2020)
3.2.2 Telmisartan Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Telmisartan Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Telmisartan Revenue in 2019
3.2.5 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Telmisartan Price by Manufacturers
3.4 Telmisartan Manufacturing Base Distribution, Product Types
3.4.1 Telmisartan Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Telmisartan Product Type
3.4.3 Date of International Manufacturers Enter into Telmisartan Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Telmisartan Market Size by Type (2015-2020)
4.1.1 Global Telmisartan Sales by Type (2015-2020)
4.1.2 Global Telmisartan Revenue by Type (2015-2020)
4.1.3 Telmisartan Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Telmisartan Market Size Forecast by Type (2021-2026)
4.2.1 Global Telmisartan Sales Forecast by Type (2021-2026)
4.2.2 Global Telmisartan Revenue Forecast by Type (2021-2026)
4.2.3 Telmisartan Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Telmisartan Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Telmisartan Market Size by Application (2015-2020)
5.1.1 Global Telmisartan Sales by Application (2015-2020)
5.1.2 Global Telmisartan Revenue by Application (2015-2020)
5.1.3 Telmisartan Price by Application (2015-2020)
5.2 Telmisartan Market Size Forecast by Application (2021-2026)
5.2.1 Global Telmisartan Sales Forecast by Application (2021-2026)
5.2.2 Global Telmisartan Revenue Forecast by Application (2021-2026)
5.2.3 Global Telmisartan Price Forecast by Application (2021-2026)
6 North America
6.1 North America Telmisartan by Country
6.1.1 North America Telmisartan Sales by Country
6.1.2 North America Telmisartan Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Telmisartan Market Facts & Figures by Type
6.3 North America Telmisartan Market Facts & Figures by Application
7 Europe
7.1 Europe Telmisartan by Country
7.1.1 Europe Telmisartan Sales by Country
7.1.2 Europe Telmisartan Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Telmisartan Market Facts & Figures by Type
7.3 Europe Telmisartan Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Telmisartan by Region
8.1.1 Asia Pacific Telmisartan Sales by Region
8.1.2 Asia Pacific Telmisartan Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Telmisartan Market Facts & Figures by Type
8.3 Asia Pacific Telmisartan Market Facts & Figures by Application
9 Latin America
9.1 Latin America Telmisartan by Country
9.1.1 Latin America Telmisartan Sales by Country
9.1.2 Latin America Telmisartan Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Telmisartan Market Facts & Figures by Type
9.3 Central & South America Telmisartan Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Telmisartan by Country
10.1.1 Middle East and Africa Telmisartan Sales by Country
10.1.2 Middle East and Africa Telmisartan Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Telmisartan Market Facts & Figures by Type
10.3 Middle East and Africa Telmisartan Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Telmisartan Products Offered
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Description, Business Overview and Total Revenue
11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Teva Telmisartan Products Offered
11.2.5 Teva Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Telmisartan Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Telmisartan Products Offered
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description, Business Overview and Total Revenue
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Telmisartan Products Offered
11.5.5 Mylan Recent Development
11.6 Reddy's Laboratories (UK)
11.6.1 Reddy's Laboratories (UK) Corporation Information
11.6.2 Reddy's Laboratories (UK) Description, Business Overview and Total Revenue
11.6.3 Reddy's Laboratories (UK) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Reddy's Laboratories (UK) Telmisartan Products Offered
11.6.5 Reddy's Laboratories (UK) Recent Development
11.7 Hema Pharmaceuticals Pvt
11.7.1 Hema Pharmaceuticals Pvt Corporation Information
11.7.2 Hema Pharmaceuticals Pvt Description, Business Overview and Total Revenue
11.7.3 Hema Pharmaceuticals Pvt Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hema Pharmaceuticals Pvt Telmisartan Products Offered
11.7.5 Hema Pharmaceuticals Pvt Recent Development
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Description, Business Overview and Total Revenue
11.8.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bayer Telmisartan Products Offered
11.8.5 Bayer Recent Development
11.9 GSK
11.9.1 GSK Corporation Information
11.9.2 GSK Description, Business Overview and Total Revenue
11.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GSK Telmisartan Products Offered
11.9.5 GSK Recent Development
11.10 Astellas Pharma Inc
11.10.1 Astellas Pharma Inc Corporation Information
11.10.2 Astellas Pharma Inc Description, Business Overview and Total Revenue
11.10.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Astellas Pharma Inc Telmisartan Products Offered
11.10.5 Astellas Pharma Inc Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Telmisartan Products Offered
11.1.5 Pfizer Recent Development
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description, Business Overview and Total Revenue
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Recent Development
11.13 Takeda
11.13.1 Takeda Corporation Information
11.13.2 Takeda Description, Business Overview and Total Revenue
11.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Takeda Products Offered
11.13.5 Takeda Recent Development
11.14 Beijing Wansheng Pharmaceutical
11.14.1 Beijing Wansheng Pharmaceutical Corporation Information
11.14.2 Beijing Wansheng Pharmaceutical Description, Business Overview and Total Revenue
11.14.3 Beijing Wansheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Beijing Wansheng Pharmaceutical Products Offered
11.14.5 Beijing Wansheng Pharmaceutical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Telmisartan Market Estimates and Projections by Region
12.1.1 Global Telmisartan Sales Forecast by Regions 2021-2026
12.1.2 Global Telmisartan Revenue Forecast by Regions 2021-2026
12.2 North America Telmisartan Market Size Forecast (2021-2026)
12.2.1 North America: Telmisartan Sales Forecast (2021-2026)
12.2.2 North America: Telmisartan Revenue Forecast (2021-2026)
12.2.3 North America: Telmisartan Market Size Forecast by Country (2021-2026)
12.3 Europe Telmisartan Market Size Forecast (2021-2026)
12.3.1 Europe: Telmisartan Sales Forecast (2021-2026)
12.3.2 Europe: Telmisartan Revenue Forecast (2021-2026)
12.3.3 Europe: Telmisartan Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Telmisartan Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Telmisartan Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Telmisartan Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Telmisartan Market Size Forecast by Region (2021-2026)
12.5 Latin America Telmisartan Market Size Forecast (2021-2026)
12.5.1 Latin America: Telmisartan Sales Forecast (2021-2026)
12.5.2 Latin America: Telmisartan Revenue Forecast (2021-2026)
12.5.3 Latin America: Telmisartan Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Telmisartan Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Telmisartan Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Telmisartan Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Telmisartan Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Telmisartan Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Telmisartan Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Telmisartan Market Segments
Table 2. Ranking of Global Top Telmisartan Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Telmisartan Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Freeze-Dried Powder
Table 6. COVID-19 Impact Global Market: (Four Telmisartan Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Telmisartan Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Telmisartan Players to Combat Covid-19 Impact
Table 11. Global Telmisartan Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Telmisartan Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Telmisartan Sales by Regions 2015-2020 (MT)
Table 14. Global Telmisartan Sales Market Share by Regions (2015-2020)
Table 15. Global Telmisartan Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Telmisartan Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Telmisartan Sales Share by Manufacturers (2015-2020)
Table 18. Global Telmisartan Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Telmisartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Telmisartan as of 2019)
Table 20. Telmisartan Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Telmisartan Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Telmisartan Price (2015-2020) (USD/Kg)
Table 23. Telmisartan Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Telmisartan Product Type
Table 25. Date of International Manufacturers Enter into Telmisartan Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Telmisartan Sales by Type (2015-2020) (MT)
Table 28. Global Telmisartan Sales Share by Type (2015-2020)
Table 29. Global Telmisartan Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Telmisartan Revenue Share by Type (2015-2020)
Table 31. Telmisartan Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 32. Global Telmisartan Sales by Application (2015-2020) (MT)
Table 33. Global Telmisartan Sales Share by Application (2015-2020)
Table 34. North America Telmisartan Sales by Country (2015-2020) (MT)
Table 35. North America Telmisartan Sales Market Share by Country (2015-2020)
Table 36. North America Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Telmisartan Revenue Market Share by Country (2015-2020)
Table 38. North America Telmisartan Sales by Type (2015-2020) (MT)
Table 39. North America Telmisartan Sales Market Share by Type (2015-2020)
Table 40. North America Telmisartan Sales by Application (2015-2020) (MT)
Table 41. North America Telmisartan Sales Market Share by Application (2015-2020)
Table 42. Europe Telmisartan Sales by Country (2015-2020) (MT)
Table 43. Europe Telmisartan Sales Market Share by Country (2015-2020)
Table 44. Europe Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Telmisartan Revenue Market Share by Country (2015-2020)
Table 46. Europe Telmisartan Sales by Type (2015-2020) (MT)
Table 47. Europe Telmisartan Sales Market Share by Type (2015-2020)
Table 48. Europe Telmisartan Sales by Application (2015-2020) (MT)
Table 49. Europe Telmisartan Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Telmisartan Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Telmisartan Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Telmisartan Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Telmisartan Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Telmisartan Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Telmisartan Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Telmisartan Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Telmisartan Sales Market Share by Application (2015-2020)
Table 58. Latin America Telmisartan Sales by Country (2015-2020) (MT)
Table 59. Latin America Telmisartan Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Telmisartan Revenue Market Share by Country (2015-2020)
Table 62. Latin America Telmisartan Sales by Type (2015-2020) (MT)
Table 63. Latin America Telmisartan Sales Market Share by Type (2015-2020)
Table 64. Latin America Telmisartan Sales by Application (2015-2020) (MT)
Table 65. Latin America Telmisartan Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Telmisartan Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Telmisartan Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Telmisartan Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Telmisartan Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Telmisartan Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Telmisartan Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Telmisartan Sales Market Share by Application (2015-2020)
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Teva Corporation Information
Table 80. Teva Description and Major Businesses
Table 81. Teva Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Teva Product
Table 83. Teva Recent Development
Table 84. Boehringer Ingelheim Corporation Information
Table 85. Boehringer Ingelheim Description and Major Businesses
Table 86. Boehringer Ingelheim Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Mylan Corporation Information
Table 95. Mylan Description and Major Businesses
Table 96. Mylan Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Mylan Product
Table 98. Mylan Recent Development
Table 99. Reddy's Laboratories (UK) Corporation Information
Table 100. Reddy's Laboratories (UK) Description and Major Businesses
Table 101. Reddy's Laboratories (UK) Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Reddy's Laboratories (UK) Product
Table 103. Reddy's Laboratories (UK) Recent Development
Table 104. Hema Pharmaceuticals Pvt Corporation Information
Table 105. Hema Pharmaceuticals Pvt Description and Major Businesses
Table 106. Hema Pharmaceuticals Pvt Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Hema Pharmaceuticals Pvt Product
Table 108. Hema Pharmaceuticals Pvt Recent Development
Table 109. Bayer Corporation Information
Table 110. Bayer Description and Major Businesses
Table 111. Bayer Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Bayer Product
Table 113. Bayer Recent Development
Table 114. GSK Corporation Information
Table 115. GSK Description and Major Businesses
Table 116. GSK Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. GSK Product
Table 118. GSK Recent Development
Table 119. Astellas Pharma Inc Corporation Information
Table 120. Astellas Pharma Inc Description and Major Businesses
Table 121. Astellas Pharma Inc Telmisartan Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Astellas Pharma Inc Product
Table 123. Astellas Pharma Inc Recent Development
Table 124. Nippon Boehringer Ingelheim Corporation Information
Table 125. Nippon Boehringer Ingelheim Description and Major Businesses
Table 126. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Nippon Boehringer Ingelheim Product
Table 128. Nippon Boehringer Ingelheim Recent Development
Table 129. Abbott Corporation Information
Table 130. Abbott Description and Major Businesses
Table 131. Abbott Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Abbott Product
Table 133. Abbott Recent Development
Table 134. Takeda Corporation Information
Table 135. Takeda Description and Major Businesses
Table 136. Takeda Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 137. Takeda Product
Table 138. Takeda Recent Development
Table 139. Beijing Wansheng Pharmaceutical Corporation Information
Table 140. Beijing Wansheng Pharmaceutical Description and Major Businesses
Table 141. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Beijing Wansheng Pharmaceutical Product
Table 143. Beijing Wansheng Pharmaceutical Recent Development
Table 144. Global Telmisartan Sales Forecast by Regions (2021-2026) (MT)
Table 145. Global Telmisartan Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global Telmisartan Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global Telmisartan Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: Telmisartan Sales Forecast by Country (2021-2026) (MT)
Table 149. North America: Telmisartan Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: Telmisartan Sales Forecast by Country (2021-2026) (MT)
Table 151. Europe: Telmisartan Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: Telmisartan Sales Forecast by Region (2021-2026) (MT)
Table 153. Asia Pacific: Telmisartan Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: Telmisartan Sales Forecast by Country (2021-2026) (MT)
Table 155. Latin America: Telmisartan Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: Telmisartan Sales Forecast by Country (2021-2026) (MT)
Table 157. Middle East and Africa: Telmisartan Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Telmisartan Players
Table 162. Telmisartan Customers List
Table 163. Telmisartan Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Telmisartan Product Picture
Figure 2. Global Telmisartan Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-Dried Powder Product Picture
Figure 5. Global Telmisartan Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Use
Figure 7. Clinic Use
Figure 8. Others
Figure 9. Telmisartan Report Years Considered
Figure 10. Global Telmisartan Market Size 2015-2026 (US$ Million)
Figure 11. Global Telmisartan Sales 2015-2026 (MT)
Figure 12. Global Telmisartan Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Telmisartan Sales Market Share by Region (2015-2020)
Figure 14. Global Telmisartan Sales Market Share by Region in 2019
Figure 15. Global Telmisartan Revenue Market Share by Region (2015-2020)
Figure 16. Global Telmisartan Revenue Market Share by Region in 2019
Figure 17. Global Telmisartan Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Telmisartan Revenue in 2019
Figure 19. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Telmisartan Sales Market Share by Type (2015-2020)
Figure 21. Global Telmisartan Sales Market Share by Type in 2019
Figure 22. Global Telmisartan Revenue Market Share by Type (2015-2020)
Figure 23. Global Telmisartan Revenue Market Share by Type in 2019
Figure 24. Global Telmisartan Market Share by Price Range (2015-2020)
Figure 25. Global Telmisartan Sales Market Share by Application (2015-2020)
Figure 26. Global Telmisartan Sales Market Share by Application in 2019
Figure 27. Global Telmisartan Revenue Market Share by Application (2015-2020)
Figure 28. Global Telmisartan Revenue Market Share by Application in 2019
Figure 29. North America Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 30. North America Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Telmisartan Sales Market Share by Country in 2019
Figure 32. North America Telmisartan Revenue Market Share by Country in 2019
Figure 33. U.S. Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 34. U.S. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 36. Canada Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Telmisartan Market Share by Type in 2019
Figure 38. North America Telmisartan Market Share by Application in 2019
Figure 39. Europe Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 40. Europe Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Telmisartan Sales Market Share by Country in 2019
Figure 42. Europe Telmisartan Revenue Market Share by Country in 2019
Figure 43. Germany Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 44. Germany Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 46. France Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 48. U.K. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 50. Italy Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 52. Russia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Telmisartan Market Share by Type in 2019
Figure 54. Europe Telmisartan Market Share by Application in 2019
Figure 55. Asia Pacific Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 56. Asia Pacific Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Telmisartan Sales Market Share by Region in 2019
Figure 58. Asia Pacific Telmisartan Revenue Market Share by Region in 2019
Figure 59. China Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 60. China Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 62. Japan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 64. South Korea Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 66. India Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 68. Australia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 70. Taiwan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 72. Indonesia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 74. Thailand Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 76. Malaysia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 78. Philippines Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 80. Vietnam Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Telmisartan Market Share by Type in 2019
Figure 82. Asia Pacific Telmisartan Market Share by Application in 2019
Figure 83. Latin America Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 84. Latin America Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Telmisartan Sales Market Share by Country in 2019
Figure 86. Latin America Telmisartan Revenue Market Share by Country in 2019
Figure 87. Mexico Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 88. Mexico Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 90. Brazil Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 92. Argentina Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Telmisartan Market Share by Type in 2019
Figure 94. Latin America Telmisartan Market Share by Application in 2019
Figure 95. Middle East and Africa Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 96. Middle East and Africa Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Telmisartan Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Telmisartan Revenue Market Share by Country in 2019
Figure 99. Turkey Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 100. Turkey Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 102. Saudi Arabia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 104. U.A.E Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Telmisartan Market Share by Type in 2019
Figure 106. Middle East and Africa Telmisartan Market Share by Application in 2019
Figure 107. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Reddy's Laboratories (UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hema Pharmaceuticals Pvt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Astellas Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Nippon Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Beijing Wansheng Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Telmisartan Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. North America Telmisartan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Telmisartan Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Europe Telmisartan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Telmisartan Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. Asia Pacific Telmisartan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Telmisartan Sales Growth Rate Forecast (2021-2026) (MT)
Figure 128. Latin America Telmisartan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Telmisartan Sales Growth Rate Forecast (2021-2026) (MT)
Figure 130. Middle East and Africa Telmisartan Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
